Cargando…
Clevidipine for severe hypertension in patients with renal dysfunction: A VELOCITY trial analysis
Introduction. Acute and severe hypertension is common, especially in patients with renal dysfunction (RD). Clevidipine is a rapidly acting (t½∼1 min) intravenous (IV) dihydropyridine calcium-channel blocker metabolized by blood and tissue esterases and may be useful in patients with RD. The purpose...
Autores principales: | PEACOCK, W FRANK, VARON, JOSEPH, EBRAHIMI, RAMIN, DUNBAR, LALA, POLLACK, CHARLES V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038587/ https://www.ncbi.nlm.nih.gov/pubmed/21091269 http://dx.doi.org/10.3109/08037051.2010.539317 |
Ejemplares similares
-
Intravenous clevidipine for management of hypertension
por: Rivera, Alma, et al.
Publicado: (2010) -
Treatment of perioperative hypertension: Is clevidipine the answer?
por: Tobias, Joseph D.
Publicado: (2009) -
Parenteral clevidipine for the acute control of blood pressure in the critically ill patient: a review
por: Peacock, W Frank, et al.
Publicado: (2009) -
Perioperative acute hypertension—role of Clevidipine butyrate
por: Kurnutala, Lakshmi N., et al.
Publicado: (2014) -
Clevidipine and COVID 19: From Hypertension to Inflammatory Response
por: Guerrero Orriach, Jose Luis, et al.
Publicado: (2022)